Company / Book Value per Share
10x Genomics, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$6.512
FY2025
5-year range
$5.963 / $7.536
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#118 of 163
Health Care
What the data says
At $6.512, 10x Genomics, Inc.'s book value per share ranks #118 of 163 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 5 years of decline, reaching $6.512.
Based on SEC 10-K filings.
$6.512 in FY2025 with a 5-year CAGR of -3.2%.
Remained stable around $6.512 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
#118 of 163 in Health CareTop 72% of 163This company $6.512 Sector average $47.405
▼
-86.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.2%, indicating a declining trend.
- In FY2025, book value per share increased 9.2% year-over-year.
- Ranks #118 out of 163 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.512 | +9.2% |
| FY2024 | $5.963 | -7.3% |
| FY2023 | $6.433 | -10.2% |
| FY2022 | $7.161 | -5.0% |
| FY2021 | $7.536 | -1.9% |
| FY2020 | $7.679 | -73.4% |
| FY2019 | $28.872 | +275.8% |
| FY2018 | -$16.426 | -69.2% |
| FY2017 | -$9.709 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026